The Change in Temporal Muscle Thickness in Stroke Patients

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

150 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-07-15

Study Completion Date

2024-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aims to evaluate the relationship between sarcopenia and functional outcomes with temporal muscle mass change.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Remote Ischemic Preconditioning on Collaterals of Atherosclerosis Stroke

NCT06170944

Stroke, Ischemic

RECRUITING NA

Study of HC-58 in Upper Limb Hemiplegic Patients After Stroke

NCT01623622

Severe Upper Limb Hemiplegia

COMPLETED PHASE2

The Establishment and Analysis of the Clinical Prediction Model of Acupuncture and Moxibustion for Stroke Recovery

NCT03946566

Stroke

UNKNOWN

Artificial Intelligence Based Comprehensive Assessment System of Carotid Plaque Stability

NCT04544657

Carotid Atherosclerosis

UNKNOWN

Non-disabling Ischemic Cerebrovascular Event With Apathy

NCT04917237

Apathy Minor Stroke Transient Ischemic Attack +1 more

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

It is well known that stroke increases the risk of developing sarcopenia . In addition, prestroke sarcopenia is associated with worse functional outcomes in patients with stroke. Temporal muscle thickness (TMT) has recently been proposed as a new marker of whole-body muscle mass and function. Measurement of temporal muscle mass by computed tomography (CT) and magnetic resonance imaging (MRI) has been studied in the literature in recent years. All stroke patients undergo cranial CT or MRI examinations at the time of admission. By evaluating the temporal muscle mass of these patients with these examinations, information about pre-stroke muscle mass and sarcopenia can be obtained. Ultrasonography (USG), on the other hand, may be a more accessible, less expensive, and safer option for assessing muscle mass in the follow-up of stroke patients. This study aims to evaluate the relationship between sarcopenia and functional outcomes with temporal muscle mass change by MRI/CT at admission and by USG in the chronic period.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Stroke Sarcopenia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of stroke
* Presence of cranial MRI/CT in hospital records

Exclusion Criteria

* Medically unstable condition (presence or high risk of impaired consciousness, respiration, or circulation).
* Severe cognitive impairment
* Patients who require intensive care unit.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No